These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 12738739

  • 1. The loss of 5alpha-reductase type I and type II mRNA expression in metastatic prostate cancer to bone and lymph node metastasis.
    Habib FK, Ross M, Bayne CW, Bollina P, Grigor K, Chapman K.
    Clin Cancer Res; 2003 May; 9(5):1815-9. PubMed ID: 12738739
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer.
    Davis JN, Wojno KJ, Daignault S, Hofer MD, Kuefer R, Rubin MA, Day ML.
    Cancer Res; 2006 Dec 15; 66(24):11897-906. PubMed ID: 17178887
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Expression of androgen receptor through androgen-converting enzymes is associated with biological aggressiveness in prostate cancer.
    Wako K, Kawasaki T, Yamana K, Suzuki K, Jiang S, Umezu H, Nishiyama T, Takahashi K, Hamakubo T, Kodama T, Naito M.
    J Clin Pathol; 2008 Apr 15; 61(4):448-54. PubMed ID: 17720776
    [Abstract] [Full Text] [Related]

  • 7. Activin A enhances prostate cancer cell migration through activation of androgen receptor and is overexpressed in metastatic prostate cancer.
    Kang HY, Huang HY, Hsieh CY, Li CF, Shyr CR, Tsai MY, Chang C, Chuang YC, Huang KE.
    J Bone Miner Res; 2009 Jul 15; 24(7):1180-93. PubMed ID: 19257827
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Type 1 and type 2 5alpha-reductase expression in the development and progression of prostate cancer.
    Thomas LN, Douglas RC, Lazier CB, Too CK, Rittmaster RS, Tindall DJ.
    Eur Urol; 2008 Feb 15; 53(2):244-52. PubMed ID: 18006217
    [Abstract] [Full Text] [Related]

  • 11. The TRPS1 transcription factor: androgenic regulation in prostate cancer and high expression in breast cancer.
    Chang GT, Jhamai M, van Weerden WM, Jenster G, Brinkmann AO.
    Endocr Relat Cancer; 2004 Dec 15; 11(4):815-22. PubMed ID: 15613454
    [Abstract] [Full Text] [Related]

  • 12. Androgen receptor immunohistochemistry on paraffin-embedded tissue.
    Loda M, Fogt F, French FS, Posner M, Cukor B, Aretz HT, Alsaigh N.
    Mod Pathol; 1994 Apr 15; 7(3):388-91. PubMed ID: 8058713
    [Abstract] [Full Text] [Related]

  • 13. Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.
    Lazier CB, Thomas LN, Douglas RC, Vessey JP, Rittmaster RS.
    Prostate; 2004 Feb 01; 58(2):130-44. PubMed ID: 14716738
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. 5alpha-reductase type 1 immunostaining is enhanced in some prostate cancers compared with benign prostatic hyperplasia epithelium.
    Thomas LN, Douglas RC, Vessey JP, Gupta R, Fontaine D, Norman RW, Thompson IM, Troyer DA, Rittmaster RS, Lazier CB.
    J Urol; 2003 Nov 01; 170(5):2019-25. PubMed ID: 14532845
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Differential alterations in 5alpha-reductase type 1 and type 2 levels during development and progression of prostate cancer.
    Thomas LN, Lazier CB, Gupta R, Norman RW, Troyer DA, O'Brien SP, Rittmaster RS.
    Prostate; 2005 May 15; 63(3):231-9. PubMed ID: 15538746
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Expression and significance of steroid 5alpha-reductase isoenzymes in benign hyperplastic prostate tissues].
    Ye LF, Zhang YF, Fang ZJ, Ding Q, Yao MS.
    Zhonghua Yi Xue Za Zhi; 2003 Aug 10; 83(15):1296-9. PubMed ID: 12930680
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.